Track topics on Twitter Track topics that are important to you
THURSDAY, Nov. 7, 2019 -- Lenalidomide significantly delays progression to symptomatic multiple myeloma in patients with smoldering multiple myeloma, according to a study published online Oct. 25 in the Journal of Clinical Oncology. Sagar Lonial,...
Original Article: Lenalidomide Delays Progression in Smoldering Multiple MyelomaNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...